AFP and hepatocellular carcinoma: On the other hand, in Japan, LT is indicated for patients with HCC within the Milan criteria or 5-5-500 criteria (1–5 lesions ≤5 cm, AFP ≤500 ng/mL) with Child-Pugh classification C liver cirrhosis [10].